Eighth Circuit· 9/29/2011
Mensing v. Wyeth, Inc.
Citations
- 658 F.3d 867
- 2011 U.S. App. LEXIS 23646
- 2011 WL 4636653
How courts have described this case
Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.
- vacating the sections of our opinion in Wyeth addressing those issues
- expressly reinstating the portion of the opinion holding that brand-name manufacturers cannot be held liable under Minnesota law for damage caused by generic drugs
Source: CourtListener parenthetical corpus (CC0).
Cited by
9 cases in this archive cite this case.
- Shirley Bell v. PfizerEighth Circuit· 2013-06-14· cited 63×
- Andrea Guarino v. Wyeth, LLCEleventh Circuit· 2013-06-25· cited 57×
- Morris v. PLIVA, Inc.Fifth Circuit· 2013-02-14· cited 44×
- Wyeth, Inc. v. Danny Weeks and Vicki WeeksSupreme Court of Alabama· 2014-08-15· cited 29×
- Phelps v. Wyeth, Inc.D. Oregon· 2013-04-02· cited 17×
- Frazier v. Mylan Inc.N.D. Georgia· 2012-12-18· cited 12×
- Metz v. Wyeth LLCM.D. Florida· 2011-11-18· cited 11×
- Moretti v. Mutual Pharmaceutical Co.D. Minnesota· 2012-02-13· cited 1×
- Penny Morris v. Wyeth, IncorporatedFifth Circuit· 2013-04-17
Cites
2 cases in this archive are cited by this case.
Sourced from CourtListener / Free Law Project (CC0).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.